Strategic partnerships Navinci is actively pursuing collaborations with academic and research institutions (Uppsala University, SciLifeLab, CBCS) and industry partners (Lumito) to advance spatial proteomics platforms, creating upsell opportunities for integrated workflows and co-developed kits.

Targeted oncology kits Recent emphasis on target specific kits for immuno-oncology such as PD1/PD-L1 suggests a clear entry point for sales of specialized in situ PLA kits to cancer research labs and translational science programs focusing on immune checkpoint biology.

In situ spatial capability Navinci’s isPLA technology enables visualization and quantification of protein interactions in native tissue contexts, appealing to labs seeking high-sensitivity spatial proteomics tools to complement existing omics pipelines.

Sales leadership Appointment of a new Chief Commercial Officer indicates a sharpened go-to-market strategy and potential expansion into new regions or customer segments, presenting opportunities for dedicated sales outreach and channel partnerships.

Expanding service portfolio Launch of Naveni Plex Omni Service and collaborations around next-generation platforms signal opportunities to upsell services, consulting, and custom assay development to streamline researchers’ spatial interactomics workflows.